MM

Moorthy Muniyappan

Active Director Director DIN 10664213
DIN 10664213 First appointment Jun 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Moorthy Muniyappan

Data last updated:

Moorthy Muniyappan is a Director at Edris Pharmaceuticals Private Limited (since 2024). The company operates in Pharma.

DIN 10664213
Primary Designation Director
Industry Pharma
First Appointment 11 Jun 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Jun 20242024Active

Board colleagues of Moorthy Muniyappan

NameDINCompanyDesignation
Mahendiran Menaka10664212Edris Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Edris Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Moorthy Muniyappan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Moorthy Muniyappan

Moorthy Muniyappan currently holds 1 directorship: Edris Pharmaceuticals Private Limited (Director, since 11 Jun 2024).

Moorthy Muniyappan was first appointed on 11 Jun 2024 as Director at Edris Pharmaceuticals Private Limited.

The current boards of Moorthy Muniyappan's companies include Mahendiran Menaka (Edris Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available